specify competitive performance, ROR
is always a primary and critical factor.
This is especially true when the particu-
lar ROR is guaranteed as the absolute
minimum that one could receive, as it
is/was in this case. Furthermore, this
type of annuity is typically marketed with
additionally components that offer pos-
sibly even more attractive performance,
that is, potentially even larger RORs and
annual payouts.
Incredibly, when not waxing irrelevantly, NAFA’s rebuttal proceeds to incorrectly assert that I state “insurers are
held to very strict advertising laws,” when
the article makes no such statement. In
fact, in the article I twice use obvious
innuendo to disparage industry compliance practices. Elsewhere (i.e., my web
site), I state views exactly opposite your
misquote; that is, that enforcement is terribly ineffective and misguided, and cite
other authorities who agree with me. Yet
somehow NAFA tries to use its misquote
and its related rambling about what it
believes are the industry’s strict compliance and regulations to dodge the articles’
vital public policy questions. However, despite NAFA’s apparent resentment of these
questions, they all are legitimate questions
which naturally arise when this annuity
and its marketing are understood. Since
in court, replies like NAFA’s are called
non-responsive, let me briefly rephrase
a few questions. 1) Given the undeniable
importance of ROR, how is it that these
annuities are marketed without sample
RORs like that shown in my article? 2)
Moreover, given that regulations are supposed to prohibit sales literature/presen-tations that have the capacity or tendency
to mislead or deceive, how is it that these
annuities are marketed without accompanying literature that highlights the readily erroneous misrepresentations and/or
misconceptions that can arise regarding
this annuity’s ROR? And 3) Would NAFA
like to work together with me to sample
100 consumers who have purchased this
type of annuity to see what they do and
don’t understand about its ROR?
There is much more in your rebuttal
that warrants a correcting response, but
I will instead close briefly with the fol-
continued from page 8s p
i d
T c
l e
m
i
t i
a
sibly even more attractive performance,
that is, potentially even larger RORs and
Incredibly, when not waxing irrel-
evantly, NAFA’s rebuttal proceeds to in-
correctly assert that I state “insurers are
held to very strict advertising laws,” when
the article makes no such statement. In
fact, in the article I twice use obvious
innuendo to disparage industry compli-
lowing two observations. One: If NAFA
on its own cannot recognize this very
problematic situation where an annuity
is described and touted as compounding money at 8% for umpteen years, after
paying a 10% bonus, and yet quite possibly is unlikely to provide consumers
even a 5.5% return, and consumers are
unaware or misinformed about such, then
it would seem the courts will have to help
NAFA finds its way. Two: While I can well
understand that NAFA does not like my
article’s message, such feelings do not
undermine the message’s validity or importance. I invite you, Ms. O’Brien, and
your NAFA members, to re-read and study
my article, and then to contact me so that
we together can set about correcting the
problems. After all, our industry will never
achieve its potential, and agents/planners
will never be respected like doctors, until
our industry adopts appropriate disclosure and actively repudiates and remedies
problematic practices. I look forward to
your reply and our future conversations.
R. Brian Fechtel
Breadwinners’ Insurance
Correction
; AXA EQUITABLE has never been
deemed insolvent nor taken under state
supervision. A sidebar (“Too Good to
be True,”) to Brian’s Fechtel’s aforemen-
tioned feature incorrectly stated that the
company had failed twice in the 20th Cen-
tury.
; ON THE ONSET of the latest round of
debate on healthcare reform, we were
told – despite the wishes of the majority
of Americans (as reflected in numerous
polls) – that the “public option” was “off
the table”.
An editorial in the June 18 British Med-
ical Journal looked at a widely acclaimed
study of health outcomes in major devel-
oped countries. That study showed that
our country “produced the worst score”
The author reported credible data
showing that we Americans achieve
worse health outcomes not only when
matched against developed nations…but
also as compared to impoverished coun-
tries like Cuba.
We accomplish this despite an annual
per capita healthcare outlay ($7,410 – 2009
data) more than double that of the United
Kingdom ($3,285) and 10 times higher
than in Cuba ($707).
This editorial was written to caution
the Conservative regime in the UK against
emulating a “U.S. style corporate dominated system”. The point was emphatically
made.
Until we address this obviously unac-
ceptable differential between spending
versus results, it is premature to dismiss
any option as arbitrarily “off the table.”
If not, why do our elected representa-
tives – putatively accountable for serv-
ing the best interests of their constituents
– continue haggling over variations of a
failed approach?
No doubt the mythology fabricated
about the “unacceptable” performance
of national healthcare programs is at the
core of this transgression.
As a former resident of Canada whose
daughter lived five years in the UK, I see
how this spin-doctored mythology is manipulated to bamboozle Americans into
thinking that a public system would not
meet their needs.
Hank George, FALU, CLU, FLMI
Greendale, WI
se
m e u
o a
ical Journal
study of health outcomes in major devel-
oped countries. That study showed that